{"id":50433,"date":"2022-11-03T13:02:30","date_gmt":"2022-11-03T12:02:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/"},"modified":"2022-11-03T13:02:30","modified_gmt":"2022-11-03T12:02:30","slug":"cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/","title":{"rendered":"Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events"},"content":{"rendered":"<div>\n<p>TORONTO&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cybin.com%2F&amp;esheet=52959575&amp;newsitemid=20221103005422&amp;lan=en-US&amp;anchor=Cybin+Inc.&amp;index=1&amp;md5=d65f1d8e9bca8322754dfc8b351dd845\" rel=\"nofollow noopener\" shape=\"rect\">Cybin Inc.<\/a> (<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Faequitasneo.com%2Fen%2Fsingle-security%2FCYBN%23%21%2Fmarket-depth&amp;esheet=52959575&amp;newsitemid=20221103005422&amp;lan=en-US&amp;anchor=NEO%3ACYBN&amp;index=2&amp;md5=360bac822d3b46079ef055bdf1b520d5\" rel=\"nofollow noopener\" shape=\"rect\">NEO:CYBN<\/a>) (NYSE American:CYBN) (\u201c<b>Cybin<\/b>\u201d or the \u201c<b>Company<\/b>\u201d), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics<sup>\u00ae<\/sup>, is pleased to announce its participation in the following upcoming investor events:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221103005422\/en\/1084589\/5\/Cybin_Primary_Logo_Blue_Final.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221103005422\/en\/1084589\/21\/Cybin_Primary_Logo_Blue_Final.jpg\"><\/a><\/p>\n<p>\n<b>Jefferies London Healthcare Conference, November 15-17, 2022<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nDoug Drysdale, Cybin\u2019s Chief Executive Officer, will present on November 15, 2022 at 8:00 a.m. GMT and host investor meetings. To listen to the presentation, please <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwsw.com%2Fwebcast%2Fjeff255%2Fcybn%2F1848852&amp;esheet=52959575&amp;newsitemid=20221103005422&amp;lan=en-US&amp;anchor=click+here&amp;index=3&amp;md5=48defcb42e1dfafc72815c48c60f31f5\" rel=\"nofollow noopener\" shape=\"rect\">click here<\/a> to register and access the webcast.\n<\/li>\n<\/ul>\n<p>\n<b>Pinsent Masons Psychedelics Panel, November 16, 2022, in London, UK<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nMr. Drysdale will participate in a panel discussion titled \u201c<!-- no quote -->Psychedelics Landscape \u2013 What can we expect?\u201d at 5:00 p.m. GMT. To listen to the panel, please <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.pinsentmasons.com%2Fevents-training%2Fpsychedelics-landscape---what-can-we-expect&amp;esheet=52959575&amp;newsitemid=20221103005422&amp;lan=en-US&amp;anchor=click+here&amp;index=4&amp;md5=f8b3777b296cdbfbd70b8b138cbebad5\" rel=\"nofollow noopener\" shape=\"rect\">click here<\/a> to register and access the webcast.\n<\/li>\n<\/ul>\n<p>\n<b>PSYCH Investor Event: Emerging Innovations in Psychedelic Healthcare, November 17, 2022, in London, UK<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nMr. Drysdale will participate in a live fireside chat at 5:00 p.m. GMT with other industry thought leaders.\n<\/li>\n<\/ul>\n<p>\nThe live and archived webcasts will also be available on the Company\u2019s investor relations website on the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.cybin.com%2Finvestors%2Fevents-and-presentations%2Fdefault.aspx&amp;esheet=52959575&amp;newsitemid=20221103005422&amp;lan=en-US&amp;anchor=Events+%26amp%3B+Presentations&amp;index=5&amp;md5=55abebd3ea78f0ac6b6967bf86413e8a\" rel=\"nofollow noopener\" shape=\"rect\">Events &amp; Presentations<\/a> page.\n<\/p>\n<p>\n<b>About Cybin<br \/>\n<br \/><\/b>Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. The Company is focused on progressing Psychedelics to Therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor &amp; Media Inquiries for Cybin:<br \/>\n<br \/><\/b>Leah Gibson<br \/>\n<br \/>Vice President, Investor Relations &amp; Strategic Communications<br \/>\n<br \/>Cybin Inc.<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x69;&#x72;&#x74;&#x65;&#97;&#109;&#64;&#99;&#121;&#98;&#105;n&#46;com\" rel=\"nofollow noopener\" shape=\"rect\">irt&#101;&#97;&#109;&#x40;&#x63;&#x79;&#x62;&#x69;&#x6e;&#46;co&#109;<\/a> \u2013 or \u2013 <a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;&#111;&#x3a;m&#101;&#x64;i&#x61;&#x40;&#99;&#x79;b&#105;&#x6e;&#46;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#101;&#100;i&#x61;&#x40;&#99;y&#x62;&#x69;&#110;&#46;c&#x6f;&#109;<\/a>\n<\/p>\n<p>\nGabriel Fahel<br \/>\n<br \/>Chief Legal Officer<br \/>\n<br \/>Cybin Inc.<br \/>\n<br \/>1-866-292-4601\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>TORONTO&#8211;(BUSINESS WIRE)&#8211;Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (\u201cCybin\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics\u00ae, is pleased to announce its participation in the following upcoming investor events: Jefferies London Healthcare Conference, November 15-17, 2022 Doug Drysdale, Cybin\u2019s Chief Executive Officer, will present on November 15, 2022 at 8:00 a.m. GMT and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50433","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TORONTO&#8211;(BUSINESS WIRE)&#8211;Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (\u201cCybin\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics\u00ae, is pleased to announce its participation in the following upcoming investor events: Jefferies London Healthcare Conference, November 15-17, 2022 Doug Drysdale, Cybin\u2019s Chief Executive Officer, will present on November 15, 2022 at 8:00 a.m. GMT and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-03T12:02:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221103005422\/en\/1084589\/21\/Cybin_Primary_Logo_Blue_Final.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events\",\"datePublished\":\"2022-11-03T12:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/\"},\"wordCount\":304,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221103005422\\\/en\\\/1084589\\\/21\\\/Cybin_Primary_Logo_Blue_Final.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/\",\"name\":\"Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221103005422\\\/en\\\/1084589\\\/21\\\/Cybin_Primary_Logo_Blue_Final.jpg\",\"datePublished\":\"2022-11-03T12:02:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221103005422\\\/en\\\/1084589\\\/21\\\/Cybin_Primary_Logo_Blue_Final.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221103005422\\\/en\\\/1084589\\\/21\\\/Cybin_Primary_Logo_Blue_Final.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events - Pharma Trend","og_description":"TORONTO&#8211;(BUSINESS WIRE)&#8211;Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (\u201cCybin\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics\u00ae, is pleased to announce its participation in the following upcoming investor events: Jefferies London Healthcare Conference, November 15-17, 2022 Doug Drysdale, Cybin\u2019s Chief Executive Officer, will present on November 15, 2022 at 8:00 a.m. GMT and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-03T12:02:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221103005422\/en\/1084589\/21\/Cybin_Primary_Logo_Blue_Final.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events","datePublished":"2022-11-03T12:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/"},"wordCount":304,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221103005422\/en\/1084589\/21\/Cybin_Primary_Logo_Blue_Final.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/","url":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/","name":"Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221103005422\/en\/1084589\/21\/Cybin_Primary_Logo_Blue_Final.jpg","datePublished":"2022-11-03T12:02:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221103005422\/en\/1084589\/21\/Cybin_Primary_Logo_Blue_Final.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221103005422\/en\/1084589\/21\/Cybin_Primary_Logo_Blue_Final.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cybin-to-participate-in-the-jefferies-london-healthcare-conference-and-upcoming-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50433"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50433\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}